Agios Recruits Rare Disease Leader Brian Goff As CEO To Execute Commercial Transition

 
• By Jessica Merrill

Leadership change comes after CEO Jackie Fouse, who will serve as board chair, oversaw the sale of Agios' cancer portfolio, a reorganization and a shift in therapeutic focus to rare diseases.

chess piece representing a leader
Agios appointed a new CEO Brian Goff • Source: Shutterstock

More from Leadership

More from Scrip